The Footnote

Beyond Small Feet: Why Children Deserve a Higher Threshold of Care and Evidence to Match

Author attribution not recorded

Large hands cradling a small shell, symbolizing the care and caution needed when treating children.

By Steven Gillingham

The Moment You Realise the Rules Are Different

It usually happens quietly. A child limps into your clinic, maybe an 11-year-old netballer clutching her ankle, or a small boy staring wide-eyed at the floor as if the lino tiles might bite. The parent does most of the talking. The child either fidgets or freezes. And as you begin the assessment, something inside you shifts.

As clinicians, we like to believe we’re adaptable. We treat truck drivers, miners, teachers, corporate executives, triathletes, and weekend warriors without changing the basic structure of our approach. Adults are variations of a template: different stories, different contexts, but fundamentally similar bodies with similar bones, similar physiology, and similar agency.

But children? Children are something else entirely.

They are not miniature adults who simply require miniature interventions. They are developing humans undergoing rapid, profound, beautifully chaotic change. Their bodies grow in spurts, their minds leapfrog through developmental stages, and their physiology behaves like a moving target. The rules you use for adults, those familiar equations of dose, load, pain, tissue response, behaviour, risk, warp the moment you try to apply them to a small, growing person.

And if you try to pretend the rules are the same? The child will show you otherwise.

It might be the way their pain shifts location. Or the way a treatment that is benign in adults becomes disproportionately influential in a growing limb. Or the way they give you a silent look that says, “I don’t understand what’s happening, and I hope you know what you’re doing.”

That’s when it hits you: Children are a vulnerable group—not abstractly, not rhetorically, but immediately, tangibly, and ethically. And the moment you see that clearly, you also see something far more unsettling:

Most of the evidence you use every day wasn’t built for them.

The Uncomfortable Truth: Children Are the Most Vulnerable Population We Treat

Vulnerability is often used as an abstract label, a word that floats through policy documents and ethics guidelines without leaving a mark. But children embody vulnerability at every level; biological, psychological, social, legal, and ethical.

Their bodies are still being written

Adult tissues behave predictably. Children’s tissues behave like half-finished sentences, open to interpretation and revision. Their growth plates are active. Their bone density is in flux. Their neuromuscular control evolves month by month. Their tendons thicken and strengthen at different rates to their muscles. Their ligaments are pliable. Their vascularity is high. Their brain is still pruning and rewiring.

This biological plasticity is both a gift and a liability. Children heal faster but they can also be injured more easily. They can remodel beautifully but they can also remodel poorly if the forces are wrong. And when an intervention goes sideways in a child, the consequences are not just immediate. They can be permanent.

Their autonomy is developing, not established

Adults can consent. Adults can refuse. Adults can articulate. Adults can negotiate.

Children? Children assent if they trust you and withdraw if they don’t. Their ability to report pain accurately is limited by vocabulary and cognitive stage. Their capacity to understand risks varies with age. Their reliance on adults for decision-making isn’t optional—it is structural.

The UN Convention on the Rights of the Child makes this explicit: children require extra protection because of their developmental vulnerability and dependency. (1)

Their psychology amplifies clinical impact

A frightening appointment can colour their perception of healthcare for life. A dismissive comment can shape their understanding of their own body. A painful intervention can become a memory that resurfaces in adulthood in ways we rarely see with adult patients.

And yet, despite all this, despite the clear scientific, ethical, and developmental reasons to treat children differently, we continue to apply adult solutions to child problems.

Why?

Because we don’t have anything else.

The Evidence Problem: Paediatrics Lives in the Shadow of Adult Research

One of the most startling statistics in modern healthcare is also one of the least discussed:

Fewer than 6% of interventional trials are paediatric-focused (5)

That means the overwhelming majority of the treatments we consider “standard practice” are validated in adults and simply borrowed for use in children.

Imagine if pilots trained on helicopters were routinely assigned to fly commercial jets because “the basic mechanics are similar.” We’d consider that absurd.

Yet in medicine, we do the equivalent daily.

Why so little research?

The barriers are obvious once you look:

Ethical complexity Getting consent for an invasive study in a toddler is worlds apart from enrolling a 45-year-old accountant eager for a cure.

Lower financial incentives A company designing orthoses or therapies rarely profits from paediatric trials. Children are a smaller market, grow out of devices quickly, and require customised approaches.

Logistical challenges School hours, parental availability, transport, attention spans, limited blood volume for testing—everything is harder.

Regulatory rigor Bodies like Australia’s NHMRC deliberately impose stricter risk thresholds for studies involving minors. (2)

Clinical researchers often describe paediatric trials as “trials squared.” Twice the complexity. Twice the administrative burden. Twice the cost. And often half the feasibility.

But the impact of that deficit is massive.

The cascade of clinical uncertainty

Because paediatric evidence is sparse:

  • We stretch adult data beyond its intended scope.

  • We infer mechanisms without validation.

  • We rely on professional experience rather than research backing.

  • We risk both overtreatment and undertreatment.

  • We normalise uncertainty as acceptable.

For many conditions seen in paediatric podiatry, hypermobile flatfoot, calcaneal apophysitis, toe-walking, juvenile bunions, paediatric tendinopathy, the evidence base is not just thin. It is porous.

We’re often stitching together:

  • Small observational studies

  • Retrospective case series

  • Adult RCTs

  • Biomechanical theory

  • Clinical intuition

And hoping the sum resembles truth.

Shamseer and colleagues point out that paediatric systematic reviews often require entirely different methodological considerations because the available studies are so heterogeneous and low powered. (4)

This isn’t a minor footnote. It’s a foundational instability.

The Ethical Imperative: High Caution Isn’t Optional—It’s Mandated

This is where clinicians must confront an uncomfortable truth:

Paediatrics requires a higher threshold of care—not by preference, but by ethical and legal obligation.

The UN Convention on the Rights of the Child

This international treaty explicitly assigns children a right to heightened protection due to their vulnerability and dependence. (1)

The NHMRC National Statement

Australia’s ethical framework requires that risks to children in research and by extension in clinical experimentation be low or negligible unless there is strong prospect of direct benefit. (2)

Professional standards (e.g., RCPCH)

Paediatric providers have a duty of safeguarding, accountability, and additional competency requirements. (8)

The doctrine of best interests

In common law, a child’s best interests override parental preferences and clinician convenience.

In adult care, ethical practice means balancing autonomy, beneficence, and justice. In paediatric care, beneficence—the obligation to protect—takes primacy.

This is the difference between “could we?” and “should we?”

What Makes Paediatric Foot & Ankle Care So Uniquely High Stakes?

Because the foot is a growth structure. Because gait is developmental. Because lower-limb biomechanics interact directly with maturation. And because small missteps have big consequences.

Growth plates: the biological landmines

The calcaneus, phalanges, metatarsals, tibia, fibula, all contain physes that are vulnerable to:

  • Excess load

  • Certain manual therapies

  • Targeted shockwave energy

  • Misplaced injections

Some interventions considered routine in adult practice flirt with entirely different risk profiles in children.

Developmental biomechanics

Children pronate more. They toe walk more. They stumble more. They adapt more. They compensate differently.

A treatment that “corrects” too aggressively can arrest natural developmental variability.

Failure to assess the whole picture

Children rarely present with isolated pathology. Their foot and ankle symptoms may be tied to:

  • Growth spurts

  • Motor coordination delays

  • Hypermobility spectrum disorders

  • Sensory processing differences

  • Fatigue

  • Overuse patterns connected to school sport or dance

A child is never “just a foot problem.” They are an evolving system.

Communication barriers

Pain scales? Mostly guesswork.

Descriptions of symptoms? Often approximations.

If a six-year-old says their foot “feels like popcorn,” you need to interpret, not interrogate.

Consent becomes a three-way relationship

Parent Child Clinician

You’re not just treating the child. You’re treating the family dynamic.

The Footnote Model of Paediatric Caution: A Narrative Framework

If adult care is linear, paediatric care is spiral-shaped requiring higher reflection, slower steps, and deeper listening.

Over the years, practitioners often develop their own quiet rules. I call these the Footnote Principles, not because they belong only to our publication, but because they represent the kind of thinking that lives in the margins of clinical guidelines, where the real wisdom often sits.

Principle 1: Proceed as though the intervention will echo for years

Because it might.

Principle 2: The absence of evidence is not evidence of safety

Silence in paediatrics is a warning, not reassurance.

Principle 3: If a treatment works in adults, assume nothing

Biological plausibility isn’t enough. Adult physiology is fully formed. Children’s physiology is in negotiation.

Principle 4: When evidence is thin, elevate shared decision-making

Parents deserve clarity about uncertainty. Children deserve involvement. Clinicians deserve humility.

Principle 5: The child’s experience matters as much as the clinical outcome

A painful, frightening, or overwhelming encounter harms far more than tissues.

These principles are not rules. They’re guard rails.

The Ways Forward: How We Bridge the Gap Between What Children Need and What Evidence Provides

We cannot continue as we are.

A Research Pipeline Built for Children

Policies like the US Best Pharmaceuticals for Children Act show what’s possible. Incentives work. Mandates work. Paediatric-first pipelines create safer therapies.

Multicentre Collaboration

Paediatric trials fail when they rely on a single hospital or clinic. But multi-site designs, even among community podiatry practices can generate meaningful sample sizes.

Registries and Longitudinal Tracking

Many paediatric orthopaedic successes (e.g., clubfoot outcomes) come from long-term registries. Podiatry could do the same.

Embedding Child Voices

Youth advisory groups are no longer optional. They improve study design, reduce attrition, and align outcomes with what actually matters: the ability to play sport, walk without pain, or return to school activities.

Better Communication Training

Clinicians must learn how to communicate uncertainty without causing alarm. Parents appreciate honesty. Children appreciate clarity.

A Culture Shift Toward Safety

Every clinician should feel comfortable saying:

“We don’t have strong evidence for this in children. Here are the options, here’s what we know, here’s what we don’t, and here’s how we keep your child safe.”

Humility is a clinical skill.

The Reflective Clinician: Why This Matters More Than Ever

This entire conversation often collapses into a single moment in clinic, the moment when a child, small and nervous, looks at you with an expression that says, “Am I safe with you?”

That expression doesn’t appear in adults. Adults may be anxious or apprehensive, but they do not radiate the pure vulnerability that children do. They are not blank slates. They are not halfway formed. They are not dependent on you to protect them from both the world and the treatment itself.

Children trust us by default. That is an extraordinary responsibility.

As clinicians, we spend years learning how to treat pathology. But we spend almost no time learning how to treat childhood.

Yet childhood is not a pathology. Childhood is an ecosystem.

And ecosystems are easy to damage.

The Footnote Conclusion: The Narrow Margin Between Harm and Help

The simple truth is this:

Children deserve better than what our current evidence base provides.

Not because our intentions are poor. Not because clinicians are careless. But because the system was not built for them.

Until the research pipeline catches up, the only ethical stance is one of heightened caution.

Do less, but do it brilliantly. Move slower, but listen deeper. Choose safer paths, even if they are less exciting. Prioritise the long-term over the short-term. Remember that a child’s experience is part of the therapeutic outcome. Remember that a negative encounter lasts a lifetime. Remember that their trust is a gift you must be worthy of.

Adult evidence may be the bridge we currently have, but we must walk children across it with care, hands outstretched, steps measured, eyes open.

And one day, with enough advocacy, research, humility, and collaboration, children won’t be walking on adult evidence at all.

They’ll be walking on something built for them.

Something safer. Something stronger. Something worthy of the small feet that depend on it.

If this article resonated… you belong in the APodA Paediatric SIG

If you care about lifting the standard of paediatric care in Australia, about better evidence, better advocacy, and better outcomes for the small humans who depend on us, then consider joining the Australian Podiatry Association Paediatric Special Interest Group.

The SIG is building a national community of clinicians who want to share cases, sharpen skills, influence policy, and push for the kind of paediatric-first research our profession urgently needs. Whether you’re new to paeds or deeply seasoned, your voice matters.

Join the APodA Paediatric SIG here: 👉 https://lnkd.in/guVCRCT9

Let’s build the future of paediatric podiatry together—one small step (and one better evidence base) at a time.

References

1.      United Nations. Convention on the Rights of the Child. New York: UN; 1989.

2.      National Health and Medical Research Council. National Statement on Ethical Conduct in Human Research. Canberra: NHMRC; 2023.

3.      Spriggs M. Understanding Consent in Research Involving Children: The Ethical Issues. Melbourne: Murdoch Children’s Research Institute; 2010.

4.      Shamseer L, Moher D, Schulz KF, et al. Do systematic reviews on paediatric topics need special methodological considerations? BMC Pediatr. 2017;17:158.

5.      Holz JT, et al. Barriers and facilitators to enrolment in paediatric clinical trials: a systematic review. Syst Rev. 2024;13:98.

6.      Jenkins M, Bruckner T, Patel N. Child vs adult randomised controlled trials in orthopaedics: a cross-sectional analysis. JAMA Pediatr. 2015;169(7):630-6.

7.      Gray WN, Schaefer MR, Resmini-Rawlinson A, Wagoner ST. Barriers to transition from paediatric to adult care: a systematic review. J Pediatr Psychol. 2018;43(5):488-502.

8.      Royal College of Paediatrics and Child Health. Child Protection Service Delivery Standards. London: RCPCH; 2022.

9.      London School of Economics. Research with Children and Other Vulnerable Groups: Ethics Guidance. London: LSE; 2025.

10. UNICEF digital archive. Convention on the Rights of the Child: supplementary materials.

Simplified complete reading view